why choose us

First received: February 06, 2023

Clinical Trial: A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

Study Status: Completed

Recruit Status: RECRUITING

Condition: Generalized Anxiety Disorder

Study Type: INTERVENTIONAL


Official Title: A Phase 2/3, Randomized, Double-blind, Parallel Group, Placebo-controlled, Flexible-dose, Multicenter Study to Evaluate the Efficacy and Safety of SEP-363856 in the Treatment of Adults With Gener

Brief Summary: A clinical study that will meaure how well SEP-363856 works and how safe it is in adults with Generalized Anixety Disorder.This study will be accepting both male and female subjects between the ages of 18 years and 65 years old.The study will be held in Approximately 50 global study centers and approximately 15 additional centers for a separate Japan population.Participation in the study can be up to approximately 12 weeks.

Read more